The Italian Implantable Cardioverter-defibrillator and Pacemaker Registry (RIDEP) has been included as a new line of investigation of RIPI considering that these implants fall into the category of devices with the highest impact on patient health and on health expenditure for medical devices: according to the National expenditure report in the public health service for purchasing medical devices published by the Ministry of Health in 2017, cardiac devices (category J01) turned out to be the second category of medical devices among those with the highest expenditure, with an amount of approximately 343 million euros.
The aim of RIDEP is to organize an information flow in collaboration with AIAC (Italian Association of Arrhythmology and Cardiac Pacing), which has acquired an important know-how with the RIP (Italian Pacemaker Registry) and RID (Italian Defibrillator Registry), which have been active for over 30 years.
This information flow will allow to collect economic and administrative data and in the same time to comprehensively monitor the devices’ performance and the related outcome data.
To correctly design the registry, it is essential, firstly, to know the scale of the phenomenon and the state of the art. The first step will be to set up a Technical Committee to comprehensively analyse the scientific literature and different databases in order to examine the existing national and international registries of these devices: what information they collect and how they are organized.
Implantable cardioverter-defibrillator and pacemaker interventions will also be mapped at a national level. All these activities will be essential to structure the RIDEP data collection.